4-desmethoxyverapamil has been researched along with clentiazem in 1 studies
| Studies (4-desmethoxyverapamil) | Trials (4-desmethoxyverapamil) | Recent Studies (post-2010) (4-desmethoxyverapamil) | Studies (clentiazem) | Trials (clentiazem) | Recent Studies (post-2010) (clentiazem) |
|---|---|---|---|---|---|
| 76 | 0 | 1 | 82 | 6 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rampe, D; Triggle, DJ; Zheng, W | 1 |
1 other study(ies) available for 4-desmethoxyverapamil and clentiazem
| Article | Year |
|---|---|
Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Isradipine; Male; Myocardium; Potassium; Pyrroles; Radioligand Assay; Rats; Vasoconstriction; Verapamil | 1991 |